Concepedia
Statistics
Publications
20
Citations
2.4K
H-Index
19
Active since
1990
Affiliations
University of Southern California(Current)
USC Norris Comprehensive Cancer Center
New York University
Los Angeles Medical Center
Kaplan (United States)
Susan Jeffers is an author at University of Southern California specializing in chemotherapy, pharmacology, and medicine.
Publications per year
1990–2004
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
Franco M. Muggia, John D. Hainsworth, Susan Jeffers et al. · Journal of Clinical Oncology · 1997 · 657 citations
Medicine, Oncology, Pharmacology +17
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
Tamar Safra, Franco M. Muggia, Susan Jeffers et al. · Annals of Oncology · 2000 · 613 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.
Beatrice Uziely, Susan Jeffers, Rut Isacson et al. · Journal of Clinical Oncology · 1995 · 478 citations
Medicine, Oncology, Pharmacology +15
A fixed-ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer
Leonard B. Saltz, Cynthia G. Leichman, Charles W. Young et al. · Cancer · 1995 · 95 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +16
Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome)
Perry P. Guaglianone, Kenneth K. Chan, Eduardo Delaflor–Weiss et al. · Investigational New Drugs · 1994 · 81 citations
Pharmacy, Pharmacokinetics, Pharmacology +7
1–5 of 20